Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
- Stanford Hospital and Clinics
Stanford, California, United States
- University of Florida College of Medicine (shands)
Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Bmt Program at Northside Hospital
Atlanta, Georgia, United States
- Emory University
Atlanta, Georgia, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Kansas Hospital
Westwood, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Dana Farber Cancer Institute/brigham & Women'S
Boston, Massachusetts, United States
- Dana Farber Cancer Institute/massachusetts General Hospital
Boston, Massachusetts, United States
- Karmanos Cancer Institute/bmt
Detroit, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic - Rochester
Rochester, Minnesota, United States
- Washington University/barnes Jewish Hospital
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center
Manhattan, New York, United States
- University of North Carolina Hospital at Chapel Hill
Chapel Hill, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University Hospitals of Cleveland/case Western
Cleveland, Ohio, United States
- Ohio State/arthur G. James Cancer Hospital
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas/md Anderson Cancer Center
Houston, Texas, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- University of Utah Med School
Salt Lake City, Utah, United States
- Virginia Commonwealth University Mcv Hospitals
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2014
- Primary completion
- 31 Oct 2017
- Completion
- 31 Oct 2017
- Last update posted
- 23 Jan 2019
- Registered enrollment
- 279
- Registry id
- NCT02208037
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.